MedMen Enterprises Inc.
MMNFF · OTC
3/25/2023 | 12/24/2022 | 9/24/2022 | 6/25/2022 | |
|---|---|---|---|---|
| Revenue | $27 | $30 | $30 | $33 |
| % Growth | -7.9% | -1.6% | -9.8% | – |
| Cost of Goods Sold | $14 | $15 | $15 | $16 |
| Gross Profit | $13 | $15 | $15 | $17 |
| % Margin | 48.3% | 50.9% | 49.4% | 51.8% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $16 | $15 | $18 | $22 |
| SG&A Expenses | $17 | $15 | $18 | $22 |
| Sales & Mktg Exp. | $1 | $1 | $0 | $1 |
| Other Operating Expenses | $7 | $2 | $2 | $5 |
| Operating Expenses | $23 | $18 | $21 | $27 |
| Operating Income | -$10 | -$2 | -$6 | -$10 |
| % Margin | -37.7% | -8.4% | -19.2% | -30.2% |
| Other Income/Exp. Net | -$27 | -$8 | -$12 | -$97 |
| Pre-Tax Income | -$37 | -$14 | -$18 | -$108 |
| Tax Expense | -$5 | $1 | $2 | -$21 |
| Net Income | -$31 | -$15 | -$20 | -$86 |
| % Margin | -114.6% | -51% | -67.4% | -259% |
| EPS | -0.023 | -0.012 | -0.016 | -0.075 |
| % Growth | -100.9% | 25.6% | 79.1% | – |
| EPS Diluted | -0.023 | -0.012 | -0.016 | -0.075 |
| Weighted Avg Shares Out | 1,341 | 1,302 | 1,302 | 1,154 |
| Weighted Avg Shares Out Dil | 1,341 | 1,302 | 1,302 | 1,154 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $12 | $11 | $12 | $5 |
| Depreciation & Amortization | $3 | $3 | $4 | $7 |
| EBITDA | -$7 | $1 | -$2 | -$96 |
| % Margin | -25.5% | 3.4% | -6% | -287.7% |